In addition, we established a prediction model, and evaluated the predictive role of ALDOA expression on survival, as well as its correlation with AKT, a target related to tumor metabolism, to provide a novel strategy for CRC targeted therapy. The gene discussed is ALDOA; the disease is neoplasm.